by McKesson Ventures | May 26, 2020 | Press Releases
Propeller Health, a digital health company dedicated to the management of asthma and COPD, announced that it has received 501(k) clearance from the FDA to connect patients using AstraZeneca’s Symbicort Inhaler to its digital health platform. The Propeller Health...
by McKesson Ventures | May 6, 2020 | Portfolio News
Novartis has announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of its Enerzair® Breezehaler® as a maintenance treatment of asthma in adult patients not...
by McKesson Ventures | Apr 20, 2020 | Portfolio News
Air pollution has long been linked to respiratory problems, particularly asthma. Thus, it came as small surprise that a new study published in the journal Nature Energy by Columbia University, Harvard, the Louisville Metro Department of Public Health and Wellness,...
by McKesson Ventures | Dec 18, 2019 | Portfolio News
Nordic company SidekickHealth announced that it has entered a strategic partnership with Bayer to provide a digital medication management and lifestyle change platform to patients with peripheral artery disease (PAD), a condition that is estimated to affect more than...
by McKesson Ventures | Dec 18, 2019 | Portfolio News
Cigna pharmacy benefit management arm Express Scripts recently unveiled the first group of digital therapeutics included in its digital health formulary. That group includes Propeller Health. The point of creating the digital health formulary was to help its health...
